Marsh | Pharmaceutical Supply Network: Pursue Full Multi-Sourcing Immed…

Minerva judgment

Adopt time-boxed mapping of critical products while concurrently protecting known single points, as this balances speed with an evidence base under hard stops on quality and patient supply, and actions can be adjusted based on mapping results

Decision owner in the teaching simulationChair of the Pharmaceutical Supply Continuity and Risk Committee in an independent teaching simulation

Human-controlled next action

The committee chair approves the scope and deadline for time-boxed mapping, and concurrently assigns owners for inventory/substitution/quality escalation thresholds for known single points

What would reverse the recommendation

If the time required for alternate supplier qualification and inventory buffer needs is unknown and may exceed the mapping deadline, full multi-sourcing for known single points should be prioritized rather than waiting for mapping results

42 · Marsh

Watch the actual operation film

Pharmaceutical Supply Network: Pursue Full Multi-Sourcing Immediately, or First Conduct Multi-Tier Mapping of Critical Products While Concurrently Protecting Known Single Points?

The Decision Room interface, case analysis, narration, captions and transcript are in English. The linked official source remains in its original language.

← Back to all 50 cases

Your browser cannot play this video. Download the MP4.Read the transcript

Official public source

Marsh · Global pharmaceutical company uncovers critical supply chain risks with Sentrisk

Evidence and endorsement boundary：Independent teaching simulation. The named consulting firm supplied the public source only; it did not use, review, endorse, sponsor, certify or commission Minerva Advisor. This evidence does not claim customer results, ROI or a permanent service-level guarantee.

Inspect the evidence, then test your own decision context.

See the first-use journey Back to all 50 cases →